Related Experiment Videos
Myocardial uptake of a bone tracer associated with hypercalcemia
Insights
Radionuclide bone imaging revealed abnormal Tc-99m uptake in the lungs, heart, and skeleton of a patient with end-stage renal disease and hypercalcemia. The cause of myocardial uptake remains unclear, with amyloidosis suggested.
Area of Science:
- Nuclear medicine
- Radiology
- Nephrology
Background:
- End-stage renal disease (ESRD) and hypercalcemia present complex diagnostic challenges.
- Radionuclide bone imaging is crucial for evaluating skeletal abnormalities.
Observation:
- A patient with ESRD and hypercalcemia underwent Tc-99m hydroxymethylenediphosphonate (HMDP) bone imaging.
- Abnormal tracer deposition was observed in the lungs, myocardium, and skeleton.
- Renal uptake was present despite anuria.
Findings:
- Computed tomography confirmed nephrocalcinosis but not myocardial calcification.
- The mechanism of myocardial Tc-99m HMDP uptake in this context is undetermined.
- Amyloidosis is a potential, though unconfirmed, explanation for the observed myocardial uptake.
Implications:
- This case highlights potential extra-skeletal Tc-99m HMDP deposition in patients with ESRD and hypercalcemia.
- Further investigation is needed to elucidate the cause of myocardial tracer uptake.
- Understanding these findings may refine diagnostic approaches in complex renal and metabolic disorders.
Abstract:
A patient with end-stage renal disease and hypercalcemia was referred for a radionuclide bone imaging study. Deposition of Tc-99m hydroxymethylenediphosphonate was apparent in the lungs and myocardium as well as in the skeleton. Renal uptake was also noted, despite anuria. Computed tomography demonstrated nephrocalcinosis but no myocardial calcification. The cause of myocardial uptake of tracer is unknown. Amyloidosis is suggested as a possibility but is not validated in this case.